M. Peeters

发表

A prospective, observational cohort study of the seasonal dynamics of airway pathogens in the aetiology of exacerbations in COPD

S. Wootton, S. Schoonbroodt, S. Clarke, 2017, Thorax.

A randomized controlled study to evaluate the immunogenicity of a trivalent inactivated seasonal influenza vaccine at two dosages in children 6 to 35 months of age

Y. Lau, Li-Min Huang, J. Devaster, 2013, Human vaccines & immunotherapeutics.

Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults

J. Devaster, M. Peeters, W. Dewé, 2013, BMC Infectious Diseases.

A Randomized Trial of Candidate Inactivated Quadrivalent Influenza Vaccine versus Trivalent Influenza Vaccines in Children Aged 3–17 Years

M. Peeters, B. Innis, J. Domachowske, 2013, The Journal of infectious diseases.

Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged ≥18 years

Chong-Jen Yu, Wen-Yuan Lin, M. Peeters, 2013, BMC Infectious Diseases.

Drivers of year-to-year variation in exacerbation frequency of COPD: analysis of the AERIS cohort

S. Wootton, S. Clarke, E. Aris, 2019, ERJ Open Research.

Phase I, randomized, observer-blind, placebo-controlled studies to evaluate the safety, reactogenicity and immunogenicity of an investigational non-typeable Haemophilus influenzae (NTHi) protein vaccine in adults.

P. van Damme, E. Aris, G. Leroux-Roels, 2016, Vaccine.

Patients with Chronic Obstructive Pulmonary Disease harbour a variation of Haemophilus species

S. Wootton, S. Schoonbroodt, S. Clarke, 2018, Scientific Reports.

Do lean markers relate to exacerbation rate in chronic obstructive pulmonary disease? Preliminary results from AERIS study

S. Wootton, E. Aris, T. Wilkinson, 2015, Proceedings of the Nutrition Society.

Immunogenicity and Safety of Inactivated Quadrivalent and Trivalent Influenza Vaccines in Children 18–47 Months of Age

M. Peeters, B. Innis, Varsha K. Jain, 2014, The Pediatric infectious disease journal.

Safety and immunogenicity of an AS03-adjuvanted A(H1N1)pmd09 vaccine administered simultaneously or sequentially with a seasonal trivalent vaccine in adults 61 years or older: data from two multicentre randomised trials.

J. Devaster, M. Peeters, L. Rombo, 2012, Vaccine.

Efficacy of inactivated split-virus influenza vaccine against culture-confirmed influenza in healthy adults: a prospective, randomized, placebo-controlled trial.

T. Vesikari, J. Devaster, M. Peeters, 2009, The Journal of infectious diseases.

A phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C adeno-associated virus vaccine.

Philip R. Johnson, S. Kochhar, J. van Lunzen, 2008, AIDS research and human retroviruses.

Drivers of year-to-year variation in exacerbation frequency of COPD: analysis of the AERIS cohort

S. Wootton, S. Clarke, E. Aris, 2019, ERJ Open Research.